Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-02-03
1997-04-08
Jacobson, Dian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
435 696, 530381, 530383, 930100, A61K 3836, A61K 3837, C07K 14755, C12N 1512
Patent
active
056187890
ABSTRACT:
Functional human factor VIII produced recombinantly is used in the treatment of human beings diagnosed to be deficient in factor VIII coagulant activity. Also provided are DNA isolates and expression vehicles encoding functional human factor VIII, as well as transformed host cells and processes for producing human factor VIII by use of recombinant DNA technology.
REFERENCES:
patent: Re32011 (1985-10-01), Zimmerman et al.
patent: 4027013 (1977-05-01), Dick et al.
patent: 4069216 (1978-01-01), Shanbrom
patent: 4085095 (1978-04-01), Bick et al.
patent: 4093608 (1978-06-01), Iga at al.
patent: 4104266 (1978-08-01), Wickerhauser
patent: 4188318 (1980-02-01), Shanbrom
patent: 4221780 (1980-09-01), Cort
patent: 4289691 (1981-09-01), Rock et al.
patent: 4294826 (1981-10-01), Feldman
patent: 4341764 (1982-07-01), Wallace et al.
patent: 4348315 (1982-09-01), Blomb ack et al.
patent: 4359463 (1982-11-01), Rock
patent: 4361509 (1982-11-01), Zimmerman et al.
patent: 4387092 (1983-06-01), Liautaud et al.
patent: 4396601 (1983-08-01), Salser et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4404131 (1983-09-01), Schwarz et al.
patent: 4495175 (1985-01-01), Chavin
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4522751 (1985-06-01), Linnao et al.
patent: 4556558 (1985-12-01), Rubinstein
patent: 4614795 (1986-10-01), Chavin
patent: 4632981 (1986-12-01), Rock et al.
patent: 4657894 (1987-04-01), Zimmerman et al.
patent: 4659805 (1987-04-01), Schilling et al.
patent: 4757006 (1988-07-01), Took, Jr. et al.
patent: 4879226 (1989-11-01), Wallace et al.
patent: 5004804 (1991-04-01), Kuo et al.
patent: 5101016 (1992-03-01), Zimmerman et al.
Fay, P.J. et al., "Proc. Natl. Acad. Sci. USA" 79: 7200-7204 (Dec. 1982).
Fulcher, C.A. et al. "Proc. Natl. Acad. Sci. USA" 79: 1648-1652 (Mar. 1982).
Knutson, G.J. & Fass, D.N. "Blood" 59(3):615-624 (Mar. 1982).
Nexis Report, Business Week (Feb. 16, 1987).
Nexis Report, Genetic Technology News (Nov. 1987).
Nexis Report, Business Week (Apr. 13, 1987).
FDC Reports, 50(18):T&G-12 (May 2, 1988).
Fay et al., Biochem & Biophys Acta, 871:268-278 (1986).
Zimmerman et al., in Haemostasis and Thrombosis, Bloom et al., ed. p. 111 (1981).
Biotechnology Law Report, vol. 6, pp. 389-390 (Sep.-Oct. 1987) Newswatch, Nov. 2, 1987, pp. 5-6, vol. 7, No. 21.
Brownlee et al., Nature 312:307 (Nov. 1984).
Maddox, J. Nature 312:306 (Nov. 1984).
de Saint Vincent, et al., Cell, 27:267-277. (1981).
McConlogue, et al., Proc. Natl. Acad. Sci. USA, 81:540-544 (1984).
Kaufman, et al., Proc. Natl. Acad. Sci. USA, 83:3136-3140 (1986).
Kempe, et al., Cell, 9:541-550 (1976).
Wahl, et al., Nature, 307:516-520 (1984).
Milbrandt, et al., Molecular and Cellular Biology, 3(7):1274-1282 (1983).
John J. Toole, et al., "A large Region (95kDa) of human factor VIII is dispensable for in vitro procoagulant activity" (1986), 5939-5942, Proc. Natl. Acad. Sci. USA., vol. 88 Aug. 1986.
Randal J. Kaufman, et al. "Site-Specific Mutagenesis to Study the Structure and Function of Factor VIII", Jan. 20-Feb. 15, 1986, p. 275, Journal of Cellular Biochemistry, Supplement 10A, 1986, UCLA Sumposia on Molecular & Cellular Biology, Alan R. Liss, Inc., New York.
Fulcher, C.A., et al., Proc. Natl. Acad. Sci. USA 79:1648-1652 (Mar. 1982).
Vehar, G.A. et al., Biochemistry 19(3):401-410 (Feb. 1980).
Weinstein, M.J. et al., "Blood" 62(5):1114-1117 (Nov. 1983).
Fay et al., "Proc. Natl. Acad. Sci. USA" 79:7200-7204 (Dec. 1982).
Fay et al., "Biochimica Et Biophysica Acta" 800:152-158 (1984).
Fay et al., Science 232:995-998 (May 1986).
Fay et al., Biochimica Et Biophysica Acta 871:268-278 (1986).
Legaz, M.E. et al., "J. Biol. Chem." 248:(11):3946-3955 (1973).
Gitschier et al., Nature 312:326-30 (1984).
Wood et al., Nature 312:330-37 (1984).
Vehar et al., Nature 312:337-42 (1984).
Toole et al., Nature 312:342-47 (1984).
Wigler et al., Cell 16:777-785 (1979).
Kaufman et al., J. Mol. Biol. 159:601-621 (1982).
Kaufman et al., Mol. Cell. Biol. 2(11): 1304-1319 (1982).
Haber et al., Somatic Cell Gen. 8(4): 499-508 (1982).
Wigler et al., PNAS USA, 77(6):3567-3570 (1980).
Murray et al., Mol. & Cell. Biol., 3(1):32-43 (1983).
Fass et al., Blood, 59(3):594-600 (1982).
Stel et al., Nature, 303:530-532 (1983) (abstract only).
Hoyer & Trabold, J. Lab & Clin. Med., 97(1):50-64 (1981).
Knutson, G.J. & Fass, D.N., Blood, 59(3): 615-624 (Mar. 1982).
Robert J. Harris, "Isolation & Characterization of Low Molecular Ion Weight, Non-Aggregated Antihomophilic Factor from Fresh Human Plasma", 1979 Dissertation Abstract.
Capon Daniel J.
Lawn Richard M.
Vehar Gordon A.
Wood William I.
Genentech Inc.
Hasak Janet E.
Jacobson Dian C.
LandOfFree
Functional human factor VIII does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functional human factor VIII, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functional human factor VIII will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397773